FR2218888B1 - - Google Patents

Info

Publication number
FR2218888B1
FR2218888B1 FR7406104A FR7406104A FR2218888B1 FR 2218888 B1 FR2218888 B1 FR 2218888B1 FR 7406104 A FR7406104 A FR 7406104A FR 7406104 A FR7406104 A FR 7406104A FR 2218888 B1 FR2218888 B1 FR 2218888B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7406104A
Other languages
French (fr)
Other versions
FR2218888A1 (de
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of FR2218888A1 publication Critical patent/FR2218888A1/fr
Application granted granted Critical
Publication of FR2218888B1 publication Critical patent/FR2218888B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/005Glycopeptides, glycoproteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/34Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7406104A 1973-02-23 1974-02-22 Expired FR2218888B1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB914973A GB1476422A (en) 1973-02-23 1973-02-23 Biological extracts

Publications (2)

Publication Number Publication Date
FR2218888A1 FR2218888A1 (de) 1974-09-20
FR2218888B1 true FR2218888B1 (de) 1976-12-03

Family

ID=9866339

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7406104A Expired FR2218888B1 (de) 1973-02-23 1974-02-22

Country Status (12)

Country Link
JP (1) JPS5063196A (de)
AU (1) AU6591074A (de)
BE (1) BE811491A (de)
DE (1) DE2408724A1 (de)
DK (1) DK141757B (de)
FR (1) FR2218888B1 (de)
GB (1) GB1476422A (de)
HU (1) HU173676B (de)
IE (1) IE39332B1 (de)
IL (1) IL44267A (de)
NL (1) NL7402455A (de)
ZA (1) ZA741189B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2410476B1 (fr) * 1977-11-30 1980-08-22 Inst Nat Sante Rech Med Application des peptidoglycanes extraits de bacteries, en particulier des bacillus a titre de medicaments, notamment stimulant l'immunite antitumorale
JPS58874B2 (ja) * 1979-08-30 1983-01-08 株式会社 目黒研究所 糖蛋白wenac及びその製造法
FR2502496A2 (fr) * 1981-03-30 1982-10-01 Pasteur Institut Fractions nouvelles extraites de bacteries aerobies, douees de proprietes antitumorales, antibacteriennes et inductrices d'interferon, et leur procede de preparation
FR2480604A1 (fr) * 1980-04-22 1981-10-23 Pasteur Institut Fractions nouvelles extraites de bacteries aerobies, douees de proprietes antitumorales, antibacteriennes et inductrices d'interferon et leur procede de preparation
US4479935A (en) * 1980-04-22 1984-10-30 Institut Pasteur Fractions extracted from aerobic bacteria, endowed with antitumoral, antibacterial and interferon inducing properties, and process for their preparation
US4871488A (en) * 1985-04-22 1989-10-03 Albany Medical College Of Union University Reconstituting viral glycoproteins into large phospholipid vesicles
US10576109B2 (en) 2014-07-16 2020-03-03 Depofarma S.P.A. Propionibacterium acnes and granulosum parietal fraction having immunomodulating action

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3450815A (en) * 1964-04-24 1969-06-17 Princeton Lab Inc Method of stimulating a host defense mechanism with an actinovaccine
US3529057A (en) * 1964-08-14 1970-09-15 Takeda Chemical Industries Ltd Purified periodic acid-oxidized mucopeptide of mycobacteria cell walls constituting a vaccine enhancing nonspecific host resistance against pathogenic bacterial infections

Also Published As

Publication number Publication date
IE39332B1 (en) 1978-09-13
JPS5063196A (de) 1975-05-29
FR2218888A1 (de) 1974-09-20
BE811491A (fr) 1974-08-22
IL44267A (en) 1978-07-31
DE2408724A1 (de) 1974-09-05
DK141757B (da) 1980-06-09
ZA741189B (en) 1975-09-24
DK141757C (de) 1980-10-27
AU6591074A (en) 1975-08-28
IE39332L (en) 1974-08-23
HU173676B (hu) 1979-07-28
GB1476422A (en) 1977-06-16
NL7402455A (de) 1974-08-27
IL44267A0 (en) 1974-05-16

Similar Documents

Publication Publication Date Title
AR201758A1 (de)
AU465372B2 (de)
AR201235Q (de)
AR201231Q (de)
AU474593B2 (de)
AU474511B2 (de)
AU474838B2 (de)
AU465453B2 (de)
AU471343B2 (de)
AU465434B2 (de)
AU450229B2 (de)
DK141757C (de)
AR201229Q (de)
AU466283B2 (de)
AU472848B2 (de)
AU476696B2 (de)
AR199451A1 (de)
AR196382A1 (de)
AR195948A1 (de)
AR200885A1 (de)
AR193950A1 (de)
AU447540B2 (de)
AR200256A1 (de)
AU461342B2 (de)
AR195311A1 (de)

Legal Events

Date Code Title Description
ST Notification of lapse